Team

Joan Ballesteros, PhD
Joan Ballesteros, PhD

Joan Ballesteros, PhD

Chairman

Joan Ballesteros is a bachelor in Chemical Sciences from the University of Barcelona and a doctor in Biomedicine from the Mount Sinai School…

Andrés Ballesteros
Andrés Ballesteros

Andrés Ballesteros

Chief Executive Officer

Spanish and American lawyer, he is a member of the New York Bar Association and MBA by Instituto de Empresa Business School. Ballesteros…

Enko N. Kiprilov MD, MS
Enko N. Kiprilov MD, MS

Enko N. Kiprilov MD, MS

Chief Scientific Officer

Dr. Kiprilov is a California Medical Board licensed physician scientist who has extensive research and clinical training in oncology, pathology, biomarkers, medical diagnostics…

Joaquin Martinez, MD PhD
Joaquin Martinez, MD PhD

Joaquin Martinez, MD PhD

Medical Director

Graduated in Medicine in 1991 from the University of Granada (Spain), Joaquin is a specialist in Hematology and PhD with honors from the…

Pilar Hernández Campo, PhD
Pilar Hernández Campo, PhD

Pilar Hernández Campo, PhD

VP of Science

Graduated in Pharmacy and holds a PhD in Hematological Malignancies from the University of Salamanca (Spain), which she obtained at the laboratory of…

Julián Gorrochategui, MD
Julián Gorrochategui, MD

Julián Gorrochategui, MD

Director Bioinformatics and Information Technologies

Julian has a dual background, both in scientific and technical areas: graduated in Biological Sciences, he followed training courses and got expertise in…

Daniel Primo Ramos, PhD
Daniel Primo Ramos, PhD

Daniel Primo Ramos, PhD

R&D Director

Daniel is a Bachelor of Biology, Biochemistry and PhD on Medicine with honors from the University of Salamanca. He is a professional scientific…

Sergio Pérez Sierra
Sergio Pérez Sierra

Sergio Pérez Sierra

Chief Financial Officer

Sergio Perez has a degree in business administration from the University of Alcalá de Henares and a Master in Financial Management from ESADE.…

Teresa Bennett, PhD
Teresa Bennett, PhD

Teresa Bennett, PhD

SVP Strategic Operations, Vivia Biotech-US

Of North American nationality, she obtained her degree in Biomedical Sciences from the University of New México, in Albuquerque, USA in a renowned…

History

Launched in September 2007, Vivia Biotech is a world pioneer of individualized medicine, profiling thousands of drugs and combinations in a single patient sample, by means of its proprietary PharmaFlow Technology Platform.

The PharmaFlow technology was originally developed in the USA by an American team who moved to Spain and launched Vivia Biotech, where they could efficiently leverage Spain’s world-leading position in altruistically donation of tissue and organ samples for research, with the first technology worldwide enabling scale research in patient samples.

Vivia has developed PharmaFlow PM, a precision medicine test for the treatment of Hematological Malignances like Leukemia and Multiple Myeloma, that seeks to identify the best treatment option for each individual patient.

Vivia has also pioneered worldwide the development of “native environment” assays in whole patient samples across several indications and multiple mechanisms of action, capable of delivering truly translational pharmacological data that correlates with patient treatment outcome.

With these assets, Vivia has successfully engaged in partnering with pharmaceutical and biotechnology companies worldwide to provide unique precision medicine capabilities for patient-centric drug development and biomarker discovery.

Vivia’s team is made of highly qualified professionals, dedicated to improve the life expectancy and quality of life of cancer patients.